148 related articles for article (PubMed ID: 25128016)
21. Recombinant activated factor VII in refractory gastrointestinal haemorrhage of unknown aetiology.
Matic I; Titlic M; Lucic I; Mirkovic F; Jurjevic M
Bratisl Lek Listy; 2008; 109(10):438-40. PubMed ID: 19166127
[TBL] [Abstract][Full Text] [Related]
22. Recombinant activated Factor VII as a hemostatic agent in very low birth weight preterms with gastrointestinal hemorrhage and disseminated intravascular coagulation.
Fischer D; Schloesser R; Buxmann H; Veldman A
J Pediatr Hematol Oncol; 2008 May; 30(5):337-42. PubMed ID: 18458565
[TBL] [Abstract][Full Text] [Related]
23. Successful treatment of massive gastrointestinal hemorrhage in acute biphenotypic leukemia with recombinant factor VIIa (NovoSeven).
Zülfikar B; Kayiran SM
Blood Coagul Fibrinolysis; 2004 Apr; 15(3):261-3. PubMed ID: 15060424
[TBL] [Abstract][Full Text] [Related]
24. Successful treatment of gastrointestinal bleeding with recombinant factor VIIa after kidney transplantation in patients with pancytopenia.
Malato A; Lo Monte AI; Anastasio R; Lo Coco L; Abbene I; Maione C; Gioviale MC; Siragusa S
Transplant Proc; 2006 May; 38(4):1031-3. PubMed ID: 16757254
[TBL] [Abstract][Full Text] [Related]
25. [Bleeding after cardiac surgery: the role of recombinant factor VIIa].
von Heymann C; Spies C; Grubitzsch H; Schönfeld H; Sander M; Volk T
Hamostaseologie; 2006 Aug; 26(3 Suppl 1):S77-87. PubMed ID: 16953296
[TBL] [Abstract][Full Text] [Related]
26. Change of coagulation after NovoSeven® use for bleeding during cardiac surgery.
Tomita E; Takase H; Tajima K; Suematsu Y
Asian Cardiovasc Thorac Ann; 2017 Feb; 25(2):99-104. PubMed ID: 28114794
[TBL] [Abstract][Full Text] [Related]
27. Successful treatment with recombinant factor VIIa for intractable bleeding at pelvic surgery.
Daniloś J; Goral A; Paluszkiewicz P; Przesmycki K; Kotarski J
Obstet Gynecol; 2003 Jun; 101(6):1172-3. PubMed ID: 12798520
[TBL] [Abstract][Full Text] [Related]
28. Recombinant-activated factor VII as hemostatic therapy in eight cases of severe hemorrhage from esophageal varices.
Romero-Castro R; Jimenez-Saenz M; Pellicer-Bautista F; Gomez-Parra M; Argüelles Arias F; Guerrero-Aznar MD; Sendon-Perez A; Herrerias-Gutierrez JM
Clin Gastroenterol Hepatol; 2004 Jan; 2(1):78-84. PubMed ID: 15017636
[TBL] [Abstract][Full Text] [Related]
29. Use of recombinant activated Factor VII for refractory after lung transplant bleeding as an effective strategy to restrict blood transfusion and associated complications.
Bhaskar B; Zeigenfuss M; Choudhary J; Fraser JF
Transfusion; 2013 Apr; 53(4):798-804. PubMed ID: 22845023
[TBL] [Abstract][Full Text] [Related]
30. Successful surgery using recombinant factor VIIa for recurrent, idiopathic nonulcer duodenal bleeding in a patient with Glanzmann's thrombasthenia.
van Buuren HR; Wielenga JJ
Dig Dis Sci; 2002 Sep; 47(9):2134-6. PubMed ID: 12353868
[TBL] [Abstract][Full Text] [Related]
31. Recombinant factor VIIa and the surgical patient.
Scarpelini S; Rizoli S
Curr Opin Crit Care; 2006 Aug; 12(4):351-6. PubMed ID: 16810047
[TBL] [Abstract][Full Text] [Related]
32. Audit of factor VIIa for bleeding resistant to conventional therapy following complex cardiac surgery.
McCall P; Story DA; Karalapillai D
Can J Anaesth; 2006 Sep; 53(9):926-33. PubMed ID: 16960271
[TBL] [Abstract][Full Text] [Related]
33. Systemic venous thrombosis after recombinant factor VIIa in the control of bleeding after cardiac surgery.
Mahmoud A; Al-Ruzzeh S; McKeague H; Cross M
Tex Heart Inst J; 2007; 34(4):485-8. PubMed ID: 18172537
[TBL] [Abstract][Full Text] [Related]
34. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage.
Brady KM; Easley RB; Tobias JD
Paediatr Anaesth; 2006 Oct; 16(10):1042-6. PubMed ID: 16972833
[TBL] [Abstract][Full Text] [Related]
35. Successful treatment of severe gastrointestinal bleeding after chemotherapy in acute myeloblastic leukemia with recombinant activated factor VII : report on one case and review of other uses in acute leukemias.
Pamuk GE; Taşçi M; Oztürk E; Demir M
Med Oncol; 2010 Mar; 27(1):16-9. PubMed ID: 19137431
[TBL] [Abstract][Full Text] [Related]
36. Recombinant activated factor VII for hemorrhage after pediatric cardiac surgery.
Singh SP; Chauhan S; Choudhary M; Vasdev S; Talwar S
Asian Cardiovasc Thorac Ann; 2012 Feb; 20(1):19-23. PubMed ID: 22371937
[TBL] [Abstract][Full Text] [Related]
37. Human recombinant activated factor VII for upper gastrointestinal bleeding in patients with liver diseases.
Marti-Carvajal AJ; Salanti G; Marti-Carvajal PI
Cochrane Database Syst Rev; 2007 Jan; (1):CD004887. PubMed ID: 17253529
[TBL] [Abstract][Full Text] [Related]
38. Intraoperative use of recombinant activated factor VII during complex aortic surgery.
Goksedef D; Panagopoulos G; Nassiri N; Levine RL; Hountis PG; Plestis KA
J Thorac Cardiovasc Surg; 2012 May; 143(5):1198-204. PubMed ID: 22285329
[TBL] [Abstract][Full Text] [Related]
39. Human recombinant activated factor VII for upper gastrointestinal bleeding in patients with liver diseases.
Martí-Carvajal AJ; Karakitsiou DE; Salanti G
Cochrane Database Syst Rev; 2012 Mar; (3):CD004887. PubMed ID: 22419301
[TBL] [Abstract][Full Text] [Related]
40. Recombinant factor VIIa (eptacog alfa): a pharmacoeconomic review of its use in haemophilia in patients with inhibitors to clotting factors VIII or IX.
Lyseng-Williamson KA; Plosker GL
Pharmacoeconomics; 2007; 25(12):1007-29. PubMed ID: 18047387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
